drugset / Trial / NCT00709254
Study of Single and Multiple Doses of Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study was designed to assess single-dose and multiple-dose PK and safety parameters utilizing a dosage of 3 mL (500 µg/mL)AeroLEF delivered via nebulization with the AeroEclipse BAN device. The study was conducted in opioid naïve subjects who were not blocked with naloxone or other opioid receptor antagonists.
Timeline
- Start
- 2001-12
- Primary completion
- 2002-01
- Completion
- 2002-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fentanyl | Other / unclassified | 200 ug | Intravenous |
| Comparator | Fentanyl | Other / unclassified | 3 ml | Intravenous |
Indications
No indication recorded.